Hoche Partners Pharma Holding S.A. Amends Procaps Group Stake
Ticker: PRCWF · Form: SC 13D/A · Filed: Oct 29, 2024 · CIK: 1863362
| Field | Detail |
|---|---|
| Company | Procaps Group, S.A. (PRCWF) |
| Form Type | SC 13D/A |
| Filed Date | Oct 29, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: schedule-13d, amendment, ownership-change
TL;DR
Hoche Partners Pharma Holding S.A. updated its stake in Procaps Group, S.A. on Oct 29, 2024.
AI Summary
Hoche Partners Pharma Holding S.A. filed an amendment (No. 12) to its Schedule 13D on October 29, 2024, regarding Procaps Group, S.A. The filing indicates a change in beneficial ownership of Procaps Group's ordinary shares. The specific details of the change in ownership percentage or number of shares are not explicitly stated in this excerpt.
Why It Matters
This filing signals a potential shift in control or significant investment activity by Hoche Partners in Procaps Group, which could impact the company's stock price and strategic direction.
Risk Assessment
Risk Level: medium — Changes in beneficial ownership filings can indicate significant investor activity, potentially leading to price volatility.
Key Players & Entities
- Hoche Partners Pharma Holding S.A. (company) — Filing entity
- Procaps Group, S.A. (company) — Subject company
- October 29, 2024 (date) — Date of event requiring filing
FAQ
What is the specific change in beneficial ownership reported by Hoche Partners Pharma Holding S.A. for Procaps Group, S.A. in this amendment?
This excerpt does not specify the exact change in beneficial ownership percentage or number of shares, only that an amendment (No. 12) was filed on October 29, 2024.
What is the CUSIP number for Procaps Group, S.A. ordinary shares?
The CUSIP number for Procaps Group, S.A. ordinary shares is L7756P 102.
What is the principal executive office address for Procaps Group, S.A.?
The principal executive office address for Procaps Group, S.A. is 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg.
Who is authorized to receive notices and communications for this filing?
The filing does not explicitly name a person authorized to receive notices and communications, but provides a contact phone number: +356 7995-6138.
What is the SIC code for Procaps Group, S.A.?
The Standard Industrial Classification (SIC) code for Procaps Group, S.A. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 1,085 words · 4 min read · ~4 pages · Grade level 9.5 · Accepted 2024-10-29 21:46:26
Key Financial Figures
- $0.01 — er) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securiti
Filing Documents
- procaps_13da12.htm (SC 13D/A) — 39KB
- ex99_24.htm (EX-99.24) — 18KB
- ex99_24image001.jpg (GRAPHIC) — 5KB
- ex99_24image002.jpg (GRAPHIC) — 5KB
- 0001019056-24-000305.txt ( ) — 73KB
of the Schedule 13D
Item 7 of the Schedule 13D is hereby amended by adding the following: Exhibit 99.24 — Letter from Gibbons P.C., as counsel to Hoche Partners Pharma Holding S.A. to the Board of Directors of Procaps Group, S.A. dated October 29, 2024 SIGNATURE After reasonable inquiry and to the best of the Reporting Person’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: October 29, 2024 hoche partners pharma holding s.a. By: /s/ Roman Sokolowski Name: Roman Sokolowski Title: Director Stonehage Fleming Corporate Service Luxembourg S.A., Director By: /s/ Alexander Ludbrook - Miles Name: Alexander Ludbrook - Miles Title: Director By: /s/ Ariane Vansimpsen Name: Ariane Vansimpsen Title: Director